Board meeting scheduled for May 14, 2026 to approve audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
Trading window closure for directors and designated persons effective from April 1, 2026 through May 16, 2026 as per insider trading code.
Regulatory intimation filed under SEBI Listing Regulations Regulation 29 for board meeting disclosure requirements.